IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Orbimed Advisors LLC

Q3 2024 Holdings

Filed 2024-11-14 | 119 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Disc Medicine Inc(IRON)COM254604101$87.7M1,785,5711.6%
Ionis Pharmaceuticals Inc(IONS)COM462222100$93.1M2,324,4471.7%
MBX Biosciences Inc(MBX)COM55287L101$99.0M3,812,2151.8%
Q32 BIO Inc(QTTB)COM746964105$100.5M2,252,9871.8%
Unitedhealth Group Inc(UNH)COM91324P102$104.7M179,0001.9%
Argenx SE(ARGX)SPONSORED ADR04016X101$110.9M204,5002.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$119.2M954,5002.2%
ARS Pharmaceuticals Inc(SPRY)COM82835W108$120.2M8,288,5102.2%
Stryker Corporation(SYK)COM863667101$124.4M344,4002.3%
Tenet Healthcare Corp(THC)COM NEW88033G407$130.0M782,0002.4%
Merck & Co Inc(MRK)COM58933Y105$149.4M1,316,0002.7%
Biogen Inc(BIIB)COM09062X103$157.6M813,0002.9%
Enliven Therapeutics Inc(ELVN)COM29337E102$203.3M7,959,5383.7%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$213.1M433,8003.9%
Boston Scientific Corp(BSX)COM101137107$274.3M3,273,0005.0%
ELI Lilly & Co(LLY)COM532457108$299.1M337,6005.4%
Sinovac Biotech LTD(SVA)SHSP8696W104$340.0M2,718,7356.2%
Edgewise Therapeutics Inc(EWTX)COM28036F105$400.9M15,021,7217.3%
PreviousPage 3 of 3